Abstract
1. The therapeutic action of an anticomplementary agent, fumaropimaric Acid (FMP), was investigated in experimental immune nephritis. 2. Nephrotoxic glomerulonephritis of variable severity was produced in rats with intravenous antiglomerular antiserum. Four to 20 hours later 51Cr. EDTA clearances, protein excretion and urinary flow rates were studied by ureteric catheterization during mannitol diuresis. 3. The action of FMP was assessed under these conditions. It was intravenously infused and serial changes in renal function in 15 nephritic and 5 control animals analysed. 4. Four of the nephritic group showed a degree of improvement related to the treatment period. Seven animals responded with statistically insignificant improvement in renal function. 5. Histological examination suggested that FMP may have reduced the number of polymorphonuclear leucocytes in the nephritic glomeruli.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
